Skip to main content
. Author manuscript; available in PMC: 2023 Mar 29.
Published in final edited form as: J Med Chem. 2023 Jan 25;66(3):2116–2142. doi: 10.1021/acs.jmedchem.2c01894

Table 6.

Mutagenic Activity and Mutagenic Index (Displayed in Parenthesis) of 5a against S. typhimurium TA98 and TA100 Strainsa

number of revertants/plate and (MI)
TA98
TA100
concentration (μg/plate) S9− S9+ S9− S9+
0b 25.67c ± 5.51 24.33 ± 9.50 206.00 ± 7.07 201.00 ± 9.90
50 26.00 ± 1.41 (1.01) 32.00 ± 11.31 (1.31) 190.50 ± 4.95 (0.92) 185.00 ± 7.07 (0.92)
150 34.50 ± 0.71 (1.34) 35.00 ± 1.41 (1.43) 187.50 ± 3.54 (0.91) 187.00 ± 5.66 (0.93)
500 38.00 ± 2.83 (1.48) 43.50 ± 6.36 (1.78) 233.00 ± 7.07 (1.13) 191.50 ± 9.19 (0.95)
1500 39.00 ± 9.90 (1.51) 30.50 ± 3.54 (1.25) 241.00 ± 2.83* (1.16) 198.50 ± 4.95 (0.98)
5000 37.50 ± 9.19 (1.46) 43.50 ± 0.71 (1.78) 241.00 ± 1.41* (1.16) 227.00 ± 9.90 (1.12)
control 34.50 ± 2.12d 137.00 ± 7.07f 260.70 ± 15.30e 1256.00 ± 102.10f
*

P < 0.05 (ANOVA) concentratons of 5a compared with negative control.

a

The results displayed represent the data for the assays in the absence (S9−) and presence (S9+) of an exogenous metabolism system.

b

Negative control (DMSO).

c

Number of revertant colonies.

d

4-Nitrophenylenediamine (NPD, 10 μg/plate).

e

Sodium azide (2.5 μg/plate).

f

2-Aminoanthracene (AA, 2.5 μg/plate).

The results are reported as means ± SD.